.jpg)
Roche Commits To $50B In U.S. Manufacturing And R&D Investments As Pharma Tariffs Loom
Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene therapy and cardiometabolic disease. The plans follow U.S. capital expenditure announcements from several big pharmaceutical companies. The post Roche Commits To $50B In U.S. Manufacturing And R&D Investments As Pharma Tariffs Loom appeared first on Above the Law.
The post Roche Commits To $50B In U.S. Manufacturing And R&D Investments As Pharma Tariffs Loom appeared first on Above the Law.
